Friday, November 22, 2024
HomeTagsFDA

FDA

FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss

Roche announced the United States Food and Drug Administration (US FDA) has approved the Vabysmo 6.0 mg single-dose prefilled syringe (PFS) for use in...

C2N Diagnostics Says FDA’s Approval of Donanemab Highlights Its Role in Helping to Determine Alzheimer’s Disease Pathology

C2N Diagnostics, a leader in advanced brain health diagnostics, is closely tracking decision by the U.S. Food and Drug Administration to approve donanemab for...

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Axogen, Inc, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+...

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its cobas® liat SARS-CoV-2, Influenza A/B &...

Bristol Myers Squibb’s Abecma (idecabtagene vicleucel) Becomes First CAR T Cell Therapy Approved in the European Union in Earlier Lines for Triple-Class Exposed Relapsed...

Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics